Paper Details

  1. Home
  2. Paper Details

Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.

Author: ChrystynHenry, De SoyzaAnthony, FeimerJan, HaughneyJohn, PadullésLaura, PascualSergi, RekedaLudmyla, RiberaAnna, Sauleda RoigJaume, SeoaneBeatriz

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

In patients with chronic obstructive pulmonary disease (COPD), Genuair (a multidose inhaler) was preferred over Breezhaler (a single-dose inhaler) for its higher patient satisfaction and overall preference. There was no significant difference in the number of patients making critical inhaler technique errors with either device.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The specific attributes of inhaler devices can influence patient use, satisfaction and treatment compliance, and may ultimately impact on clinical outcomes in patients with chronic obstructive pulmonary disease (COPD). AIMS: To assess patient preference, satisfaction and critical inhale...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415437/

データ提供：米国国立医学図書館（NLM）

Patient Preferences and Inhaler Devices: A Comfortable Journey with Genuair

This study investigates patient preference for different inhaler devices, specifically Genuair and Breezhaler, in the management of chronic obstructive pulmonary disease (COPD). COPD is a chronic lung disease that affects millions of people worldwide, and proper medication delivery through inhalers is crucial for managing the condition. The researchers focused on patient preference, satisfaction, and the ease of use of each inhaler. The findings clearly indicated that patients significantly preferred Genuair over Breezhaler. They reported greater satisfaction and found Genuair easier to use, despite both devices having a low rate of critical inhaler technique errors.

Patient-Centric Care: A Comfortable Journey

The study emphasizes the importance of patient-centric care and considering individual preferences when choosing medication delivery methods. The researchers' findings demonstrate that a simple preference for one inhaler device over another can significantly impact a patient's overall satisfaction and compliance with their treatment. This research is like discovering a comfortable camel saddle, making the journey across the desert more enjoyable and easier to endure.

Improving COPD Management: A Step Towards Comfort

This research underscores the importance of exploring different medication delivery options to optimize patient comfort and improve adherence to treatment. The findings suggest that a simple change in inhaler device can positively impact the patient's experience, making the journey of managing COPD a more pleasant one.

Dr.Camel's Conclusion

This study highlights the importance of patient preference in medication delivery methods, particularly for chronic conditions like COPD. The findings suggest that choosing a device that is comfortable and easy to use can significantly improve patient satisfaction and adherence to treatment. This underscores the need for a patient-centric approach to care, where individual preferences are considered to optimize the patient's journey to better health.

Date :
  1. Date Completed 2015-10-26
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

25927321

DOI: Digital Object Identifier

PMC4415437

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.